Bicara Therapeutics Inc. (BCAX) reporting calendar
Bicara Therapeutics Inc. files periodic reports with the SEC as BCAX on Nasdaq. Atlas tracks 7 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 19 Jul 2026 – 5 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 11 May 2026
- Reports on record
- 7
How this window is derived. Derived from this issuer's own filing history: 7 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open BCAX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 11 May 2026 | 41 days | 0001628280-26-033429 |
| 10-K | 31 Dec 2025 | 30 Mar 2026 | 89 days | 0001628280-26-022010 |
| 10-Q | 30 Sep 2025 | 10 Nov 2025 | 41 days | 0002023658-25-000109 |
| 10-Q | 30 Jun 2025 | 12 Aug 2025 | 43 days | 0002023658-25-000098 |
| 10-Q | 31 Mar 2025 | 13 May 2025 | 43 days | 0002023658-25-000039 |
| 10-K | 31 Dec 2024 | 27 Mar 2025 | 86 days | 0002023658-25-000012 |
| 10-Q | 30 Sep 2024 | 12 Nov 2024 | 43 days | 0002023658-24-000002 |
Source: SEC EDGAR company submissions for CIK 0002023658. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.